Reaction

Red Blood Cells Urine Positive reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 957 reports · 29 co-occurring drugs

As of the last recalculation, Red Blood Cells Urine Positive appears in 957 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 350.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Alemtuzumab235350.0354.3
Dimenhydrinate109250.9253.5
Basiliximab4485.285.6
Ganciclovir2963.563.7
Ganciclovir Sodium2961.461.6
Methylprednisolone24150.350.4
Heparin Sodium3048.949.1
Diltiazem Hydrochloride Extended-Release Tablets2345.045.1
Methylprednisolone Sodium Succinate7839.739.8
Calcium Gluconate2036.836.9
Sodium Bicarbonate3736.036.0
Sodium Bicarbonate Injection,3736.036.0
Febuxostat Tablets 40 Mg1634.834.8
Febuxostat Tablets 80 Mg1634.834.8
Cimetidine1534.434.5
Mycophenolic Acid4632.832.8
Amikacin1924.724.7
Febuxostat1621.121.1
Cetirizine Hydrochloride Allergy2820.720.7
Cetirizine Hydrochloride Tablets2820.720.7
Diphenhydramine Hydrochloride13520.520.5
Acyclovir9720.420.5
Ranitidine13416.916.9
Micafungin Sodium615.515.5
Tafamidis814.914.9
Oxybutynin1813.613.6
Pazopanib Hydrochloride1310.610.6
Dalfampridine319.79.7
Ixekizumab116.56.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.